ESTIMATED
05/09/2024
05/09/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$1.49 | -$1.49 | -$1.49 |
Q2 2024 | 2 | -$1.47 | -$1.34 | -$1.41 |
Q3 2024 | 0 | -$1.70 | -$1.70 | -$1.70 |
Q4 2024 | 0 | -$2.20 | -$2.20 | -$2.20 |
MEI Pharma, Inc. last posted its earnings results on Thursday, May 9th, 2024. The company reported $-1.37 earnings per share for the quarter, topping analysts' consensus estimates of $-1.38 by $0.0099999999999998. The company had revenue of 0 for the quarter and had revenue of 48.82 M for the year. MEI Pharma, Inc. has generated $-5 earnings per share over the last year ($-4.78 diluted earnings per share) and currently has a price-to-earnings ratio of 0.71. MEI Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 24th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/09/2024 | Q3 2024 | -$1.38 | -$1.37 | 0.01 | $37,500 | $0 | 02/13/2024 | Q2 2024 | -$1.46 | -$1.66 | -0.2 | $100,000 | $0 | 11/09/2023 | Q1 2024 | -$2.12 | $8.46 | 10.58 | $65.30 M | 09/26/2023 | Q4 2023 | -$3.25 | -$1.51 | 1.74 | $1.46 M | 05/11/2023 | Q3 2023 | -$2.60 | -$2.17 | 0.43 | $346,750 | $5.89 M | 02/09/2023 | Q2 2023 | -$3.20 | $1.54 | 4.74 | $4.42 M | $32.74 M | 11/14/2022 | Q1 2023 | -$2.60 | -$2.57 | 0.03 | $8.73 M | 09/08/2022 | Q4 2022 | -$3.60 | -$2.44 | 1.16 | $11.41 M | 05/23/2022 | Q3 2022 | -$3.40 | $2.55 | 5.95 | $9.69 M | 02/10/2022 | Q2 2022 | -$3.80 | -$1.92 | 1.88 | $5.26 M | $18.22 M | 11/10/2021 | Q1 2022 | -$2.60 | -$3.11 | -0.51 | $10.56 M | $13.39 M | 09/02/2021 | Q4 2021 | -$3.00 | -$1.49 | 1.51 | $4.17 M | $10.12 M | 05/06/2021 | Q3 2021 | -$3.00 | -$4.55 | -1.55 | $2.42 M | 02/04/2021 | Q2 2021 | -$3.00 | -$1.43 | 1.57 | $2.92 M | $9.17 M | 11/10/2020 | Q1 2021 | -$1.40 | $0.13 | 1.53 | $3.67 M | $3.83 M | 09/09/2020 | Q4 2020 | $2.60 | -$3.69 | -6.29 | $45.07 M | $25.50 M | 05/07/2020 | Q3 2020 | -$2.80 | -$0.82 | 1.98 | $1.24 M | 02/06/2020 | Q2 2020 | -$3.60 | -$5.15 | -1.55 | $1.58 M | $1.01 M | 11/07/2019 | Q1 2020 | -$3.20 | -$0.81 | 2.39 | $1.33 M | $1.16 M | 08/28/2019 | Q4 2019 | -$4.00 | $0.86 | 4.86 | $715,857 | $1.13 M |
---|
A. MEI Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 24th, 2024 based off last year's report dates.
A. In the previous quarter, MEI Pharma, Inc. (NASDAQ:MEIP) reported $-1.37 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.38 by $0.0099999999999998.
A. The conference call for MEI Pharma, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for MEI Pharma, Inc.'s latest earnings report can be read online.
A. MEI Pharma, Inc. (NASDAQ:MEIP) has a recorded annual revenue of $48.82 M.
A. MEI Pharma, Inc. (NASDAQ:MEIP) has a recorded net income of $48.82 M. MEI Pharma, Inc. has generated $-4.78 earnings per share over the last four quarters.
A. MEI Pharma, Inc. (NASDAQ:MEIP) has a price-to-earnings ratio of 0.71 and price/earnings-to-growth ratio is 0.02.